Association of nirmatrelvir/ritonavir and remdesivir as treatment for SARS-CoV-2 infection in immunocompromised patients with hematologic malignancies. Series of four cases
Rev. esp. quimioter
; 36(6): 655-657, dec. 2023. tab
Article
in English
| IBECS
| ID: ibc-228260
Responsible library:
ES1.1
Localization: ES15.1 - BNCS
Full text:
Available
Collection:
National databases
/
Spain
Database:
IBECS
Main subject:
Ritonavir
/
Cytochrome P-450 CYP3A Inhibitors
Limits:
Aged
/
Female
/
Humans
/
Male
Language:
English
Journal:
Rev. esp. quimioter
Year:
2023
Document type:
Article
Institution/Affiliation country:
General University Hospital of Castellón/Spain